Functional restoration of cirrhotic liver after partial hepatectomy in the rat

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 897-902

  Hashimoto, Masaji ^a   Watanabe, Goro ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Aminopyrine clearance; Functional capacity; Functional regeneration; Indocyanine green; Liver fibrosis; Liver regeneration; Morphological regeneration; PCNA

Indexed keywords

AMINOPHENAZONE; CYCLINE; INDOCYANINE GREEN; THIOACETAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DETERIORATION; EVALUATION; EXPERIMENTAL MODEL; FUNCTIONAL ASSESSMENT; LIVER CIRRHOSIS; LIVER CLEARANCE; LIVER FIBROSIS; LIVER FUNCTION; LIVER REGENERATION; LIVER STRUCTURE; LIVER WEIGHT; MALE; NONHUMAN; PARAMETER; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; HEPATECTOMY; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER FUNCTION TESTS; LIVER REGENERATION; MALE; MURIDAE; RATS; RATS, WISTAR; REFERENCE VALUES; STATISTICS; THIOACETAMIDE;

EID: 20644453553     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Conn HO, Atterbury CE: Cirrhosis. In: Schiff L, Schiff ER (Eds.). Diseases of the Liver. 7th Edition. Philadelphia: J.B. Lippimcott Co., 1993; pp. 875-878.
2. Hoofnagle JH, Bisceglie AMD: The treatment of chronic viral hepatitis. New Engl J Med 1997; 336:347-356.
3. Markowitr JS, Martin P, Conrad AJ, et al: Prophylaxis against Hepatitis B Recurrence following liver transplantation, using combination Lamivudine and hepatitis B immue globulin. Hepatology 1998; 28:585-589.
4. Sheiner PA, Boros P, Klion FM, et al: The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology 1998; 28:831-838.
5. Shiratori Y, Imazeki F, Moriyama M, et al: Histologic Improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000; 132:517-524.
6. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T: Human liver regeneration after major hepatic resection. Ann Surg 1987; 206:30-39.
7. Rabinovici N, Wiener E: Liver regeneration after partial hepatectomy in carbon tetrachloride-induced cirrhosis in the rat. Gastroenterology 1961; 40:416-422.
8. Gupta DN: Nodular cirrhosis and metastasising tumors produced in the liver of rats by prolonged feeding with thioacetamide. J Path Bact 1956; 72:415-426.
9. Higgins GM, Andersen RM: Experimental pathology of the liver. The restoration of liver of white rat following surgical removal. Arch Pathol 1931; 12:186-202.
10. Ishigami Y, Masuzawa M, Miyoshi E, et al: Clinical applications of ICG finger monitor in patients with liver disease. J Hepatol 1993; 19:232-240.
11. Hashimoto M, Sanjo K: Functional capacity of the liver after 2/3 hepatectomv in the rats. Surgery 1997; 121:690-697.
12. Hashimoto M, Watanabe G: Functional capacity of the cirrhotic liver after partial hepatectomy in the rats. Surgery 1999; 126:541-547.
13. Kawasaki S, Sugiyama Y, Iga T, et al: Hepatic clearances of antipyrine, indocyanine green, and galactose in normal subjects and in patients with chronic liver diseases. Clin Pharm Therapeutics 1988; 44:217-224.
14. Garland P, Degraef C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 1989; 22:383-392.
15. Wolf HK, Michalopoulos GK: Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology 1992; 15:707-713.
16. Imamura H, Kawasaki S, Shiga J, Bandai Y, Sanjo K, Idezuki Y: Quantitative evaluation of parenchymal liver cell volume and total hepatocyte number in cirrhotic patients. Hepatology 1991; 14:448-453.
17. Kawasaki S, Imamura H, Bandai Y, Sanjo K, Idezuki Y: Direct evidence for the intact hepatocyte theory in patients with liver cirrhosis. Gastroenterology 1992; 102:1351-1355.
18. Hashimoto M, Watanabe G: Hepatic parenchymal cell volume and the indocyanine green tolerance test. J Surg Res 2000; 92:222-227.
19. Shiratori Y, Shiina S, Imamura M, et al: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C-viral infection in Japan. Hepatology 1995; 22:1027-1033.
20. Kershenobich D, Vargas F, Garcia-Tsao G, Perez TR, Gent M, Rojkind M: Colchicine in the treatment of cirrhosis of the liver. New Engl J Med 1998; 318:1709-1713.
21. Bruch R, Genia O, Aeed H, Alexiev R, Nagler A, Avni Y, Pines M: Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology 2001; 33:379-386.
22. Ueki T, Kaneda Y, Tsutsui H, et al: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med 1999; 5:226-230.
23. Koike Y, Shiratori Y, Sato S, et al: Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesion. Hepatology 2000; 32:1216-1223.
24. Grellier L, Mutimer D, Ahmed M, et al: Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348:1212-1215.
25. Fausto N: Hepatic regeneration. In: Zalim D, Boyer TD (Eds.). Hepatology - a textbook of liver disease. Vol 1. Philadelphia: Saunders, 1990; pp. 49-65.
26. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K: Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984; 95:586-592.
27. Yildirim SI, Poulsen HE: Quantitative liver functions after 70% hepatectomy. Eur J Clin Invest 1981; 11:469-472.
28. Hansen BA, Poulsen HE: Changes in the hepatic capacity of urea-N synthesis, galactose elimination and antipyrine clearance following 70% hepatectomy in the rat. Scand J Lab Invest 1986; 46:233-237.
29. Moody FG, Rikkers LF, Aldrete JS: Estimation of the functional reserve of human liver. Ann Surg 1974; 180:592-598.
30. Hunton DB, Bollman JL, Hoffman HN: Studies of hepatic functions with indocyanine green. Gastroenterology 1960; 39:713-724.
31. Henderson JM, Warren WD: A method of measuring quantitative hepatic function and hemodynamics in cirrhosis: the changes following distal splenorenal shunt. Jpn J Surg 1986; 16:157-168.
32. Hepner GW, Vesell ES: Quantitative assessment of hepatic function by breath analysis after oral administration of [C]aminopyrine. Ann Intern Med 1975; 83:632-638.
33. Vesell ES: The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clin Pharmacol Ther 1979; 26:275-286.
34. Hepner GW, Vesell ES: Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine: effect of phenobarbital, disulfiram and portal cirrhosis. New Engl J Med 1974; 291:1384-1388.
35. Reichen J, Arts B, Shaforth U, Zimmermann A, Zeltner TB, Zysset T: Aminopyrine N-demethylation by rats with liver cirrhosis: evidence for the intact cell hypothesis: a morphometric functional study. Gastroenterology 1987; 93:719-726.
36. Sendama I, Hemptinne B, Lambotte L: Recovery of liver function in partially hepatectomized rats evaluated by aminopyrine demethylation capacity. Hepatology 1985; 5:629-633.
37. Wieser W: Cost of growth in cells and organisms: general rules and comparative aspects. Biol Res Camb Philos Soc 1994; 68:1-33.
38. Cameron GR, Karunaratne WAE: Caron tetrachloride cirrhosis to liver regeneration. J Path Bact 1936; 42:1-21.
39. Shea SM, Manseau EJ: Experimental toxic cirrhosis in the rat. Am J Pathol 1996; 52:55-67.
40. Zimmermann T, Franke H, Dargel R: Studies on lipid and lipoprotein metabolism in rat liver cirrhosis induced by different regimens of thioacetamide administration. Exp Pathol 1986; 30:109-117.
41. Jezequel AM, Mancini R, Rinaldesi ML, et al: Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 1989; 8:42-52.
42. MacDonald RA: Experimental pigment cirrhosis; its production in rats by feeding cholinedeficient diet with excess iron. Am J Pathol 1960; 36:499-519.
43. Kountouras JB, Billin BH, Scheuer PJ: Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984; 65:305-311.